Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

ESPERITE NV (ESP) delays publication of Annual Report 2017

Esperite N.V.
Posted on: 30 Apr 18

Amsterdam, The Netherlands - 30 April 2018

Esperite regrets to announce that due to technical issues and despite the constant efforts provided by the different teams involved, the publication of the Annual Report 2017 must be postponed until further notice.

The company will communicate as soon as it is possible and expect a date before the end of May 2018.

About ESPERITE
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar:  +31 575 548 998  -  ir@esperite.com  or visit the websites at www.esperite.comwww.genoma.com and www.cryo-save.com .

***

This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

Delay AR17


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Esperite N.V. via GlobeNewswire
HUG#2188897
GlobeNewswire
globenewswire.com

Last updated on: 01/05/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.